THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.
DelistedCIK 1419051fmd_0ENZ5MX7B73FWM189B67GKZ21NManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2010 to Sep 30, 2024, 56 periods
| Line item | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of revenue | 0 | 0 | 0 | 0 | – | – | 0 | 0 | 0 | 0 |
| Gross profit | 0 | (0) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Research and development | – | – | 0 | – | – | – | 1 | 1 | 1 | 1 |
| Total operating expenses | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 2 |
| Compensation and benefits | – | – | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Operating income | (0) | (1) | (1) | (1) | (1) | (1) | (2) | (2) | (3) | (2) |
| Interest expense | 0 | (0) | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
| Other non-operating income (expense) | (0) | (0) | (0) | (0) | (1) | (1) | (0) | (1) | (1) | (0) |
| Income before taxes | – | – | – | – | – | – | (2) | (3) | (4) | (2) |
| Income tax expense | – | – | – | – | – | – | – | 0 | 0 | 0 |
| Net income from continuing operations | (1) | (1) | (1) | – | – | – | – | (3) | (4) | (2) |
| Net income | (0) | (1) | (1) | (1) | (2) | (2) | (2) | (3) | (4) | (2) |